• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 49
  • 20
  • 16
  • 6
  • 3
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • Tagged with
  • 110
  • 83
  • 37
  • 17
  • 16
  • 16
  • 16
  • 14
  • 14
  • 12
  • 12
  • 12
  • 11
  • 11
  • 10
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
91

Omissão do segundo dia da medicação antiemética como estratégia para a redução do custo da profilaxia de náuseas e vômitos induzidos por quimioterapia: resultados de um estudo fase III / The omission of day 2 of Antiemetic Medications is a cost saving strategy for improving chemotherapy-induced nausea and vomiting control: Results of a randomized phase III trial

Lajolo, Paula Philbert [UNIFESP] 30 July 2008 (has links) (PDF)
Made available in DSpace on 2015-07-22T20:50:31Z (GMT). No. of bitstreams: 0 Previous issue date: 2008-07-30. Added 1 bitstream(s) on 2015-08-11T03:25:42Z : No. of bitstreams: 1 Publico-10756.pdf: 198016 bytes, checksum: b1b248dd88de1aeab5859b81fa05e4c2 (MD5) / INTRODUÇÃO: Os antagonistas 5HT-3 e corticosteróides são drogas importantes no controle da emese induzida por quimioterapia Apresentam controle de 50-80% da emese aguda porém controlam menos de 50% da emese tardia induzida por quimioterapia. Em estudo prévio realizado em nossa instituição, observou-se que o controle da emese tardia poderia ser melhorado com a omissão do segundo dia dos antagonistas 5HT-3. Reportamos aqui os resultados de um estudo fase III confirmando os achados prévios PACIENTES E MÉTODOS: Estudo fase III randomizado e duplo-cego foi realizado na FMABC Santo André/Brasil. Pacientes submetidos a esquemas quimioterápicos alta e moderadamente emetogênicos pela 1ª vez receberam Ondasetron 16mg e Dexametasona 20 mg IV antes da quimioterapia no Dia 1. Foram então randomizados em dois grupos. Grupo A recebeu metoclopramida VO 10mg 8/8hs, Granisetron VO 0,5mg/dia,e dexametasona VO 8mg /dia por 2 dias, a partir do dia 2 (dias 2 e 3). Metoclopramida VO 10 mg 8/8 hs foi continuada no dia 4. Grupo B recebeu placebo no dia 2 e o mesmo esquema de drogas dia 3 e dia 4. Pacientes foram entrevistados no dia 1 e dia 6. RESULTADOS: 73 pacientes foram incluídos no estudo. Os grupos foram bem balanceados em relação as suas características clinicas com exceção ao melhor controle da emese aguda no grupo A (p=0,04). Proteção completa de náuse a e vômito tardios (do dia 2 ao 5 ), foi semelhante em ambos os grupos (30% vs. 32%; p=0.5). Em análise multivariada, tanto a proteção completa da emese aguda (p=0.001) quanto grupo de estudo (p=0.06) estavam independentemente relacionados à proteção completa da náusea e vômito tardios. Selecionando apenas os pacientes que obtiveram controle completo da emese na fase aguda, pacientes do grupo B obtiveram maior proteção da emese tardia (85% vs 50% ,p=0,02). CONCLUSÃO: A omissão da medicação antiemética no dia 2 representa uma estratégia para redução do custo da profilaxia da emese tardia induzida pela quimioterapia. / BACKGROUND: Nausea and vomiting are important symptoms observed in cancer patients. In a previous study we showed that delayed chemotherapyinduced nausea and vomiting (CINV) control could be potentially improved by skipping the administration of a 5HT3-antagonist on day 2. We report here a trial confirming our previous findings. PATIENTS/METHODS: A phase-IIIrandomized- placebo-controlled trial was conducted in which patients received (IV) ondansetron 16mg, dexamethasone 20mg and ranitidine 50mg before highly/moderately emetogenic chemotherapy (day 1).Starting on day 2, all patients received metoclopramide 10mg PO q8 hours (days 2,3 and 4, Dexamethasone 8mg QD (days 2 and 3) and Ranitidine 150mg q12 hours (days 2 and 3). Patients were randomized to receive either Granisetron 0.5mg PO (days 2 and 3) (Group A) or Placebo instead for Granisetron on day 2 and Granisetron 0.5mg on day 3 and 4 (Group B) RESULTS: 73 patients were enrolled. Groups were similar regarding clinical characteristics, despite better control during the acute phase of CINV in group A (p=0.04). Complete delayed protection from nausea/vomiting (DCPNV) from day 2 to 5 was similar in both groups. (30% vs. 32%; p=0.5). Analyzing DCPNV by logistic regression multivariate analyses, acute complete protection from nausea/vomiting (ACPNV) (p=0.001) and study group (p=0.06) were independently associated with DCPNV. Selecting patients who achieved ACPNV, we observed that group B had a superior DCPNV (85% vs 50%, p=0.02). CONCLUSION: DCPNV can be improved just by skipping day 2 of 5HT3- antagonists. Future studies should compare this inexpensive strategy with NK1- antagonists or second generation 5HT3-antagonists. Key words: delayed chemotherapy-induced nausea and vomiting, tachyphylaxis, cost- saving regimen, antiemetics, Granisetron/administration and dosage. / TEDE / BV UNIFESP: Teses e dissertações
92

Avaliação de náuseas e vômitos induzidos por quimioterapia, história de tabagismo e uso crônico de opioides como fatores de risco para náuseas e vômitos no pós-operatório (NVPO) de pacientes oncológicos: estudo observacional prospectivo / Evaluation of nausea and vomiting induced by chemotherapy, history of smoking and chronic use of opioids as risk factors for postoperative nausea and vomiting (PONV) of oncological patients: observational prospective study

Léia Alessandra Pinto Yamada 08 June 2018 (has links)
Introdução: Náuseas e vômitos pós-operatórios são queixas importantes no período pós-operatório e seu controle adequado em pacientes oncológicos ainda é um desafio. Na avaliação de fatores de risco relacionados à NVPO é importante melhorar a estratificação dos pacientes a serem submetidos à anestesia e cirurgia, de maneira a propor intervenções que diminuam a NVPO. Neste estudo avaliou-se as variáveis náuseas e vômitos induzidos por quimioterapia (NVIQ), o uso crônico de opioides prévio à cirurgia, a história detalhada de tabagismo e o processo de cessação do tabagismo no período anterior à cirurgia em pacientes oncológicos. Métodos: Foi realizado um estudo observacional, prospectivo de 1829 pacientes oncológicos submetidos à cirurgia oncológicas de médio e grande porte entre maio de 2014 e novembro de 2015 no Instituto do Câncer do Estado de São Paulo (ICESP), Brasil. NVPO foram avaliados nas primeiras 24 horas de pós-operatório. Os dados foram obtidos por meio de entrevistas e de consulta aos prontuários. Foi realizada análise bivariada para estudar os potenciais fatores associados à NVPO. A análise de regressão logística múltipla identificou um novo modelo para previsão de NVPO através do estado de tabagismo detalhado. Resultados: A incidência global de NVPO foi de 30,8%. Houve correlação entre NVPO e as variáveis sexo feminino, idade, não tabagismo, NVIQ e história de cinetose. O risco de NVPO em fumantes foi de 14,1%, de 18,1% naqueles que pararam de fumar até um mês, 24,7% naqueles que pararam de fumar entre um mês e seis meses, 29,4% naqueles que pararam de fumar há mais de seis meses e 33,9% naqueles que nunca fumaram. Esta correlação gerou um novo modelo preditor para previsão de NVPO incluindo o histórico de tabagismo detalhado ao invés da variável dicotômica usada pelo modelo de Apfel, curva ROC com modelo de Apfel - AUC: 63,7% e novo modelo: 67,9%. Não foi encontrada relação entre o tipo de cirurgia e uso opioide crônico com NVPO. Conclusão: As variáveis sexo feminino, idade, não tabagismo, NVIQ, história prévia de cinetose foram confirmadas como fatores de risco para NVPO e um novo modelo preditor foi identificado pela associação entre NVPO e a história tabágica na população oncológica / Introduction: Nausea and vomiting are the main sources of discomfort in the postoperative period and their adequate control in oncological patients is still defiant. During the evaluation of PONV risk factor it is important to better stratify the patients to be submitted to anesthesia and surgery, in order to propose interventions that lead to the decrease in PONV. In this study, we evaluated chemotherapy induced nausea and vomiting (CINV), chronic use of opioid prior to surgery and the detailed history of smoking and of smoking quitting in oncological patients. Methods: This was an observational prospective study of 1829 oncological patients submitted to surgery from May 2014 and November 2015 in the Institute of Cancer of the State of São Paulo (ICESP), Brazil. PONV was evaluated in the first 24 hours after surgery. The data was obtained by interviews and medical records consultation. Bivariate analysis was performed to study potential factors associated to PONV. Multiple logistics analysis identified a new prediction model to PONV adding detailed smoking status. Results: Incidence of PONV was of 30.8%. There was correlation among PONV and female sex, age, non-smoking, CINV and previous motion sickness. Risk of PONV was of 14.1% in smokers, 18.1% in individuals that quit smoking in less than a month, 24.7% in individuals that quit smoking between one and six months, 29.4% in those who quit smoking more than six months and 33.9% in individuals that never smoked. This correlation generated a new PONV prediction model, including detailed smoking status rather than the Apfel dichotomous variable of smoking (yes/no), ROC curve using Apfel´s model - AUC - 63.7% and new model - 67.9%. There was no correlation between type of surgery, chronic opioid use and PONV. Conclusion: Female sex, age, non-smoking, CINV, previous motion sickness was confirmed as risk factors for PONV and a new PONV prediction model was identified through the association between PONV and the detailed history of smoking and smoking quitting in the oncological population
93

Palonosetrona e ondansetrona na profilaxia de náuseas e vômitos pós-operatórios em mulheres com 60 anos ou mais submetidas a colecistectomias videolaparoscópicas: estudo aleatório e duplamente encoberto

Braga, Estevão Luiz Carvalho January 2017 (has links)
Submitted by Verônica Esteves (vevenesteves@gmail.com) on 2018-01-11T14:25:05Z No. of bitstreams: 2 license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5) Dissertação Estêvão Braga.pdf: 573304 bytes, checksum: ad209c591d600ecfd064c313a95814b9 (MD5) / Approved for entry into archive by Verônica Esteves (vevenesteves@gmail.com) on 2018-01-11T14:26:31Z (GMT) No. of bitstreams: 2 license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5) Dissertação Estêvão Braga.pdf: 573304 bytes, checksum: ad209c591d600ecfd064c313a95814b9 (MD5) / Made available in DSpace on 2018-01-11T14:26:31Z (GMT). No. of bitstreams: 2 license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5) Dissertação Estêvão Braga.pdf: 573304 bytes, checksum: ad209c591d600ecfd064c313a95814b9 (MD5) Previous issue date: 2017 / Hospital Federal de Bonsucesso / Contexto: Apesar de diminuir com o envelhecimento, a incidência de náuseas e vômitos pósoperatórios (NVPO) permanece elevada em pacientes idosos, gerando possíveis repercussões pósoperatórias que podem ser catastróficas em indivíduos com menor reserva fisiológica. OBJETIVOS: Nosso objetivo principal foi testar a hipótese de que o uso único de palonosetrona na indução da anestesia, não é inferior ao uso da ondansetrona na indução, seguida do uso regular, em mulheres com 60 anos ou mais. MÉTODOS: Oitenta e duas mulheres com 60 anos ou mais, não fumantes, submetidas a colecistectomias laparoscópicas, receberam como intervenção palonosetrona 75 μg administradas por via endovenosa (ev) na indução de anestesia ou ondansetrona 4 mg, administrados iv na indução de anestesia seguido por administrações regulares de 4 mg a cada 8 horas no pós-operatório. A freqüência e intensidade das NVPO, os efeitos adversos, a necessidade de medicação de resgate e o nível de satisfação com a terapia antiemética foram avaliados no pós-operatório com 2, 6, 24 e 48 horas. RESULTADOS: Não houve diferença significativa durante os períodos de avaliação na freqüência e na intensidade das NVPO entre os grupos estudados. A freqüência total de náuseas pós-operatórias (0-48 horas) entre as pacientes que receberam palonosetrona e ondansetrona foi de 60 vs 55% (p = 0,65), e a freqüência total de vômitos foi de 35 vs 25% (p = 0,33), respectivamente. Não houve diferenças significativas nos efeitos adversos, no uso de medicação de resgate, como também no nível de satisfação com a terapia antiemética utilisada. CONCLUSÃO: A administração de dose única da palonosetrona na indução de anestesia foi tão eficaz quanto a administração da ondansetrona na indução, seguida de sua administração regular, para a profilaxia de NVPO em mulheres com 60 anos ou mais, submetidas a colecistectomia laparoscópica. / Background: Although decreases with aging, the incidence of postoperative nausea and vomiting ( PONV) remains high in elderly patients, generating possible postoperative repercussions that can be catastrophic in individuals with less physiological reserve. OBJECTIVES: Our primary objective was to test hypothesis that the single use of palonosetron at induction of anaesthesia, is non inferior to the use of ondansetron at induction, followed by regular doses, in women aged 60 years or older. METHODS: Eighty-two women aged 60 years or older, non-smokers, undergoing laparoscopic cholecystectomy received as intervention palonosetron 75 μg administered intravenously (iv) at the induction of anaesthesia or ondansetron 4 mg administered iv at the induction of anaesthesia followed by regular administrations of 4 mg every 8 hours postoperatively. The frequency and intensity of PONV, the frequency of adverse effects, the need for rescue medication and the level of satisfaction with antiemetic therapy were evaluated postoperatively at 2, 6, 24 and 48 hours. RESULTS: There was no significant difference in the frequency or intensity of PONV among the groups studied during the evaluation periods. The total frequency of postoperative nausea (0-48 hours) among patients receiving palonosetron and ondansetron was 60 vs 55% (p = 0.65), and the total frequency of vomiting was 35 vs 25% (p = 0.33), respectively. There were also no differences in adverse effects, use of rescue medication and level of satisfaction with antiemetic therapy. CONCLUSION: The administration of a single dose of palonosetron at the induction of anaesthesia was as effective as the regular administration of ondansetron at induction followed by regular administration for the prophylaxis of PONV in women 60 years of age or older who underwent laparoscopic cholecystectomy.
94

Redução do jejum pré e pós-operatório em pacientes submetidos à colecistectomia videolaparoscópica : ensaio clínico randomizado

Souza, Ana Waleska de Menezes Seixas 31 March 2014 (has links)
The abbreviation of preoperative fasting with the provision of clear fluid two hours before the operation and the early introduction of a diet in the postoperative period, are indications that may bring benefits for the surgical patient. Objective: To assess the effects of reducing the time of preoperative fasting and early feeding in the postoperative period, in patients undergoing a laparoscopic cholecystectomy. Method: a randomized and controlled clinical trial conducted in a private hospital in Aracaju, Brazil, in which the variables investigated were: the presence of gastric residue, vomiting, bronchoaspiration and satisfaction in the post-operative period of 80 patients, who were randomly divided into two groups, the test group (40 patients) ingested 100 ml of coconut water two hours before induction of anesthesia and the control group (40 patients) followed the conventional fasting for six hours without ingest liquids and were submitted to laparoscopic cholecystectomy. A previous monitoring of patients still under consultation was done, those who met the inclusion criteria received guidance on the development of research and responded to a questionnaire with questions related to the occurrence of symptoms. The numerical scale was used for each patient, with the aim of evaluating the degree of satisfaction related to the reduction of the time of fasting in the preoperative period and early feeding in the postoperative period. The comparative analysis of groups was performed using the Mann-Whitney and Fischer´s Exact Test. The significance level of 5% was considered, while for the descriptive analysis percentages and tables were used. Results: There was no aspiration or regurgitation of gastric contents during the anesthetic induction. There were no deaths or post-operative complications. With regard to residual gastric volume, there was no significant difference between the test and control groups (p=0,704). In addition, there was no significant difference between the groups for the vomiting variable (p>0.05). After having their fasting reduced, the test group had a significant degree of satisfaction (p<0.001). Conclusion: The reduction of pre and post-operative fasting showed less discomfort with apparent satisfaction in patients undergoing laparoscopic cholecystectomy. / A abreviação do jejum pré-operatório com oferta de líquido claro duas horas antes da operação e a introdução precoce de dieta no pós-operatório, são indicações que poderão trazer benefícios para o paciente cirúrgico. Objetivo: Avaliar os efeitos da redução do tempo de jejum pré-operatório e alimentação precoce no pós-operatório, em pacientes submetidos à colecistectomia videolaparoscópica. Método: ensaio clínico randomizado e controlado realizado em um hospital particular de Aracaju, no qual as variáveis investigadas foram: a presença de resíduo gástrico, vômito, broncoaspiração e satisfação no pós-operatório de 80 pacientes, que foram aleatoriamente divididos em dois grupos, o grupo teste (40 pacientes) ingeriu 100 ml de água de coco duas horas antes da indução anestésica e o grupo controle (40 pacientes) seguiu o jejum convencional de seis horas sem ingerir líquidos e foram submetidos à colecistectomia videolaparoscópica. Foi feito um acompanhamento prévio dos pacientes ainda em consultório, aqueles que atenderam aos critérios de inclusão receberam orientações sobre o desenvolvimento da pesquisa e responderam a um questionário com perguntas relativas à ocorrência dos sintomas. A escala numérica foi empregada para cada paciente, com o intuito de avaliar o grau de satisfação relacionada à redução do tempo de jejum no pré-operatório e alimentação precoce no pós-operatório. A análise comparativa de grupos foi feita através do Teste de Mann- Whitney e Exato de Fischer. Considerou-se o grau de significância de 5% e para a análise descritiva foram utilizadas percentagens e tabelas. Resultados: Não houve aspiração ou regurgitação do conteúdo gástrico durante a indução anestésica. Não houve óbito nem complicações pós-operatória. No que se refere a volume residual gástrico, não houve diferença significativa entre os grupos teste e controle (p = 0,704). Também não houve diferença significativa entre os grupos para a variável vômito (p > 0,05). Após ter o seu jejum reduzido, o grupo teste teve um grau de satisfação significativo (p < 0,001). Conclusão: A redução do jejum pré e pós-operatório, sinalizaram menos desconforto com aparente satisfação em pacientes submetidos à colecistectomia videolaparoscópica
95

Påverkar val av anestesimedel den dagkirurgiska patientens postoperativa återhämtning? : En jämförelse mellan Propofol och Sevofluran

Blåder, Karin, Sunneskär, Karl January 2021 (has links)
Intravenös anestesi med Propofol eller inhalationsanestesi med gasen Sevofluran är de två vanligaste anestesiformerna i Sverige. Syftet med studien vara att undersöka om patienters postoperativa återhämtning skiljer sig åt beroende på om de sövts med Propofol eller Sevofluran. Datainsamlingen till studien genomfördes med systematisk litteraturöversikt baserad på integrativ metod. Både kvalitativa och kvantitativa studier samlades in, men enbart kvantitativa artiklar inkluderades. Resultatet visade att det under den postoperativa återhämtningen var vanligt förekommande med två postoperativa komplikationer, smärta samt illamående och kräkningar. Resultatet visar inga statistiskt signifikanta skillnader när det gällde dessa beroende på val av anestesimedel. Men vidare studier behövs inom ämnet, framför allt om kön eller ålder kan vara ytterligare påverkande faktorer. / Intravenous anesthesia with Propofol or inhalation anesthesia with the gas Sevoflurane are the two most common forms of anesthesia in Sweden. The purpose of the study was to investigate whether patient's postoperative recovery differs depending on whether they have been anesthetized with Propofol or Sevoflurane. The data collection for the study was carried out with a systematic literature review based on integrative research Both qualitative and quantitative studies were collected, but only quantitative articles were included. The results showed that during postoperative recovery it was common with two postoperative complications, pain, nausea, and vomiting. The results show no statistically significant differences in these depending on the choice of anesthetic agents. However, further studies are needed in the subject, especially if gender or age can be additional influencers.
96

Beratungsanlässe in der Allgemeinmedizin: Kinder und Jugendliche als Patientengut sowie Übelkeit und Erbrechen als häufiger Beratungsanlass

Klauß, Steffi 11 October 2012 (has links)
Daten der SESAM 2-Studie wurden analysiert, um die Konsultationsprävalenz, Beratungsergebnisse und Therapie von Patienten mit den Symptomen Übelkeit und/oder Erbrechen sowie die Beratungsanlässe von Kinder und Jugendlichen auszuwerten. Dazu wurden 8874 Patienten in dem Zeitraum vom 01.10.1999 bis 30.09.2000 von 270 teilnehmenden sächsischen Hausärzten untersucht und die Ergebnisse in standardisierten Antwortbögen dokumentiert. Zusätzlich wurden die erhobenen Daten mit anderen internationalen Studien verglichen (Dutch Transition Project, Beach Studie). 9,1% der Patienten, die ihren Hausarzt aufsuchten, waren zwischen 0 und 19 Jahren alt. Kinder und Jugendliche stellen sich zumeist auf Grund von Husten, Fieber, Schnupfen und Halsbeschwerden bei ihrem Hausarzt vor. Die Konsultationsprävalenz dieser Patientengruppe lag zwischen 10,2% im April und 6,2% im August. Mit steigendem Alter ist eine Zunahme des Spektrums unterschiedlicher Beratungsanlässe zu verzeichnen. Es ist daher unerlässlich für den Allgemeinmediziner Erfahrungen in der Anamnese, Diagnostik und Behandlung von Erkrankungen im Kindes- und Jugendalter zu sammeln. Die Konsultationsprävalenz für Übelkeit und Erbrechen lag in unserer Studie für alle Altersgruppen zusammen bei 1,9%. Kinder und Jugendliche litten im Vergleich zu Erwachsenen häufiger unter diesen Symptomen. Geschlechtsspezifische Unterschiede fanden sich nicht. Bei lediglich 4,1% der diesbezüglichen Konsultationen wurden diagnostische Maßnahmen ergriffen, die über eine körperliche Untersuchung hinausgingen. Die am häufigsten gestellte Diagnose bei diesen Beschwerden war eine nicht-infektiöse Gastroenteritis. In 76,3% der Fälle wurden zur Behandlung Medikamente verordnet. Übelkeit und/oder Erbrechen ist ein häufiger Konsultationsanlass. Potentiell abwendbar gefährliche Verläufe sind selten.
97

“Imprisoned in my own body”- Women's experiences of Hyperemesis Gravidarum during pregnancy : A qualitative study

Choudri, Tooba January 2022 (has links)
Introduction: Hyperemesis gravidarum (HG) in pregnancy can cause severe and persistent vomiting, nausea, dehydration, vitamin and mineral deficiencies. The symptoms can have varying degrees of impact on women's physical, emotional, social, and marital lives and affect their quality of life. Some women voluntarily terminate their pregnancies due to HG. Despite the severe consequences, the etiology of this disorder remains unknown. HG is thought to be caused by a mixture of hormonal variables and genetics. Various therapies have been documented with varying degrees of efficacy. Nevertheless, there is a lack of research on the actual causes of the disease and effective medications, as well as a lack of research on patients' experiences with HG, its treatments, and its consequences. Aim: This thesis aims to examine women's own experiences of HG, with the following research questions: How do women experience HG in their daily lives? What kind of support do they have in coping? What kind of approach do they receive from the health care system? What medical interventions were offered to them? and how effective were they perceived? Method: The thesis adopts a qualitative approach. Some prominent women's groups on Facebook were used to spread the information about the study, and 20 women in Sweden who had suffered from HG during pregnancy and had given birth no more than four years ago were interviewed individually online via Zoom. The data was analyzed using the thematic analysis method by creating sub-themes and themes through coding. Findings: The analysis revealed two themes: 'Trapped in my own body' and 'Longing for optimal HG care'. The first theme described the women's daily lives, which were significantly affected by HG. Due to severe vomiting and nausea, many of them were bedridden for long periods and unable to take care of their children or do household chores. They had significant problems with eating food, drinking water, odors, and oral hygiene. Many were unable to work, and most were on long-term sick leave. Women relied on their partners and families to cope with HG. The disease was compounded by mental health problems such as isolation, loneliness, sadness, and even depression. The second theme revealed that medications and their perceived effects were experienced differently. No drug could completely cure the disease in every case, and HG treatments were not considered optimal by any woman. Medical facilities often lacked knowledge about the disease and the drugs available, and there were no functioning care plans. Lack of knowledge meant that most women in the early stages of pregnancy were not taken seriously by the health system, and it took a long time for many of them to receive appropriate treatment. Conclusion: HG was perceived by women as a severe disease that caused significant physical and psychological obstacles in life and made women feel imprisoned in their bodies. Their most considerable support in coping with this illness was their partners and family. Despite these severe problems, most received inadequate care at health facilities mainly due to ignorance of the disease. This study has highlighted a great need for clear organizational structures, a working care plan, and more knowledge of HG in all health departments. Evidence-based national and local guidelines are needed to improve the availability and quality of health care. Based on the women’s experiences, the findings of this study may provide essential insights for implementing such guidelines in clinical practice.
98

Postoperativt illamående och kräkning bland patienter i dagkirurgi : En studie om följsamhet till rutin vid ett medelstort regionsjukhus i Sverige

Halatchev, Julia, Triumf, Viktor January 2017 (has links)
Postoperativt illamående och kräkning är fortfarande ett vanligt förekommande problem i samband med anestesi. Förutom obehaget med detta finns även medicinska risker som aspiration av maginnehåll eller sårruptur. PONV går att förebygga till viss del med hjälp av läkemedel, pre-operativ riskskattning samt genom anpassad anestesimetod. Genom att göra en riskskattning kan personal uppskatta vilka patienter som ligger i riskzonen för PONV och därigenom anpassa behandlingen. Syftet med denna studie var att undersöka hur riktlinjerna för att riskbedöma och förebygga PONV följs vid en dagkirurgisk avdelning. Studien genomfördes som en prospektiv observationsstudie med en kvantitativ ansats. Sammanlagt deltog 49 patienter i studien. De fick svara på om de kände av illamående och/eller kräkningar 2 samt 4 timmar postoperativt. Datan analyserades sedan i  Package for Social Science (SPSS). Resultatet visade att rutinen följdes i 63% av fallen och att förekomsten av PONV var på 16%. Slutsatser som kan dras ifrån detta är att rutinen för PONV följs i samma utsträckning som många andra rutiner inom hälso- och sjukvård och att förekomsten av PONV är som förväntat utifrån tidigare studier. Rutinen borde dock kunna följas i fler än 63% av fallen. Vidare forskning kring huruvida ökad följsamhet skulle kunna sänka förekomsten av PONV behövs.
99

The effect of serotonin and serotonin receptor antagonists on motion sickness in Suncus murinus

Naylor, Robert J., Javid, Farideh A. January 2002 (has links)
No / In the present study, we investigated the effect of 5-hydroxytryptamine (5-HT) and 5-HT receptor agonists and antagonists on motion sickness in Suncus murinus, and the possibility that the emetic stimulus of 5-HT can alter the sensitivity of the animals to the different emetic stimulus of motion sickness. 5-HT (1.0, 2.0, 4.0 and 8.0 mg/kg ip) induced emesis and that was antagonised by methysergide (1.0 mg/kg ip), the 5-HT4receptor antagonist sulphamate[1-[2-[(methylsulphonyl)amino]ethyl]-4-piperidinyl]methyl-5-fluoro-2-methoxy-1H-indole-3-carboxylate (GR125487D; 1.0 mg/kg ip) and granisetron (0.5 mg/kg ip). Pretreatment with 5-HT caused a dose-related attenuation of the emetic response induced by a subsequent motion stimulus, which was not significantly modified by methysergide, granisetron or GR125487D pretreatment. (+)-1-(2,5-Dimethoxy-4-iodophenyl)-2-amino-propane (DOI; 0.5 and 1.0 mg/kg ip), 8-hydroxy-2(di-n-propylamino)tetralin (8-OH-DPAT; 0.1 mg/kg ip) but not methysergide, GR125487D or granisetron, attenuated motion-induced emesis, and that was not affected by pretreatment with ketanserin (2.0 mg/kg, ip) or N-{2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl}-N-(2-pyridinyl)cyclohexanecarboxamide trihydrocholoride (WAY-100635; 1.0 mg/kg ip), respectively. Indeed, ketanserin alone (0.1, 0.3, 1.0 and 2.0 mg/kg ip) attenuated motion sickness. These data indicate that 5-HT1/2, 5-HT3 and 5-HT4 receptors are involved in the induction of 5-HT-induced emesis. However, agonist action at the 5-HT1A/7 and 5-HT2 receptors, and antagonist action at the 5-HT2A receptors can attenuate motion sickness in S. murinus.
100

Uticaj lokalnog anestetika na bol posle laparoskopske holecistektomije / The influence of local anesthetic on pain after laparoscopic cholecystectomy

Jovanović Dejan 28 June 2016 (has links)
<p>UVOD. Bilijarna kalkuloza je najče&scaron;će oboljenje hepatobilijarnog sistema, a holecistektomija predstavlja jedan od najče&scaron;će izvođenih operativnih zahvata. Laparoskopska holecistektomija je danas zlatni standard lečenja holelitijaze. Laparoskopska holecistektomija je pokazala pobolj&scaron;anje u klinički značajnim ishodima kao &scaron;to su skraćenje operativnog vremena, kraća hospitalizacija, smanjenje jačine i trajanja postoperativnog bola i brži povratak dnevnim i radnim aktivnostima. Postoperativna bol i vreme potpunog oporavka ostaju dva glavna problema posle nekomplikovane laparoskopske holecistektomije koje bi trebalo pobolj&scaron;ati. Bol koji je povezan sa laparoskopskom holecistektomijom je kompleksan i multifaktorijalan. On nastaje o&scaron;tećenjem tkiva, disekcijom i uklanjanjem žučne kesice iz svoje lože, stimulacijom periportalnih nerava, iritacijom dijafragme, mehaničkim i hemijskim interakcijama gasa i pneumoperitoneuma, incizijama portova. Istraživanja su označila parijetalni i visceralni bol kao dva glavna mehanizma nastanka bola kod laparoskopske holecistektomije. Bol se ne može meriti nego proceniti jer je subjektivni osećaj. Pokazalo se potrebnim da se na čvr&scaron;ćim naučnim osnovama da odgovor na pitanje da li je moguće blokirati parijetalni i visceralni bol posle laparoskopske holecistektomije u akutnoj fazi. CILJEVI. Cilj studije je da uporedi standardnu analgeziju (ne-opioidnu) (grupa O) sa davanjem parijetalne blokade (grupa P), ili davanjem visceralne blokade (grupa V), ili sa obe date blokade (grupa P+V). Primarni ishodi studije su bolesnikov procenjeni bol pre operacije i posle operacije na 1, 2, 4, 6, 12, 24, 48 sati i 7. dana. Sekundarni ishodi studije su bolesnikova procenjena mučnina na 1,2,4,6,12 sati i bolesnikova procenjena mobilnost 1. 2. i 7. dan. HIPOTEZA. Blokada postoperativnog visceralnog bola i blokada postoperativnog parijetalnog bola posle laparoskopske holecistektomije putem intraperitonealne lokalne infiltracije anestetikom i putem lokalne infiltracije anestetikom pristupnih laparoskopskih portova može značajno smanjiti rani postoperativni bol. MATERIJAL I METODE. Ova prospektivna, randomizirana jednostruko slepa studija je započela septembra 2014. godine i trajala je do januara 2016. godine. Istraživanje je sprovedeno na Klinici za abdominalnu, endokrinu i transplantacionu hirurgiju i Urgentnom centru Kliničkog centra Vojvodine u Novom Sadu kod bolesnika operisanih metodom laparoskopske holecistektomije. Rad je podeljen u nekoliko celina. 1. Procena veličine uzorka; 2. Procena podobnosti za studiju; 3. Anketiranje i uključivanje u studiju; 4. Razvrstavanje u grupe i operativni rad; 5. Period postoperativnog praćenja; 6. Statistička obrada i pisanje rada.<br />1. Procena veličine uzorka. Studija je realizovana podelom bolesnika u 4 grupe. Neophodni broj bolesnika je izračunat uzimajući podatke iz pilot istraživanja slične studije iz 2012. godine. Veličina uzorka je računata za primarni ishod studije&nbsp; (bolesnikov procenjen bol sa NAS) na pretpostavci da treba biti 20% smanjenja bola u prvom postoperativnom satu, uz verovatnoću Tip 1 gre&scaron;ke &alpha;=0.05 i Tipa 2 gre&scaron;ke &beta;=0.10 da postigne adekvatnu statističku snagu oko 80% i da otkrije 20% razlike u srednjoj vrednosti procenjenog bola jedan sat nakon laparoskopske&nbsp; holecistektomije. Procenjeni broj ispitanika po grupama prema zadatim kriterijumima je bio (P+V=65; P=68; V=68; O=65). Studija je započela uključivanjem prvog bolesnika u studiju a zavr&scaron;ena ispunjenim periodom praćenja sve dok poslednji bolesnik nije doneo upitnike o bolu, mučnini i kretanju. 2. Procena podobnosti za studiju. U periodu studije ukupan broj holecistektomiranih bolesnika je bio 1024 (440 klasično i 584 laparoskopski). Samo pogodni bolesnici su anketirani (584) i pročitali su informacioni list o istraživanju. Uključivanje ili procena podobnosti bolesnika za studiju sprovedena je na osnovu uključnih i isključnih kriterijuma. U studiju nije uključeno ukupno 226 bolesnika. Od tog broja 82 bolesnika je odbilo učestvovati u studiji a 144 bolesnika nije ispunilo uključne postavljene kriterijume. Svojim potpisom potvrdilo je uče&scaron;će u studiji 358 bolesnika. 3. Anketiranje i uključivanje u studiju. Nakon prijema bolesnika u bolnicu ispitivači su uzimali anamnezu i bolesnicima je ponuđen informacioni list i informisani pristanak. Nakon čitanja informacije, potpisivanja informisanog pristanka i zadovoljavanja&nbsp; uključnih i isključnih kriterijuma 358 bolesnika je uključeno u studiju. Obavljena je preoperativna priprema i ispitivači su popunili deo podataka u individualnom listu. 4. Razvrstavanje u grupe i operativni rad. Neposredno preoperativno od strane nezavisne osobe neuključene u studiju napravljena je randomizacija izabranih (n=358) u studijske grupe tablicama slučajnog izbora, tako da bolesnici nisu znali kojoj grupi pripadaju, dok su operater i osoblje to znali na početku operacije (jednostruko slepa studija). Nakon randomizacije i operacije bolesnici pripadaju jednoj od sledeće 4 grupe: Kontrolna grupa O=89, u kojoj su bolesnici sa urađenom laparoskopskom&nbsp; holecistektomijom bez visceralne blokade anestetikom i bez parijetalne blokade anestetikom. Eksperimentalna grupa P=88, u kojoj su bolesnici sa urađenom laparoskopskom holecistektomijom bez visceralne blokade anestetikom i sa parijetalnom blokadom anestetikom. Eksperimentalna grupa V=92, u kojoj su bolesnici sa urađenom laparoskopskom holecistektomijom sa visceralnom blokadom anestetikom i bez parijetalne blokade anestetikom. Eksperimentalna grupa P+V=89, u kojoj će biti bolesnici sa urađenom laparoskopskom holecistektomijom sa visceralnom blokadom anestetikom i sa parijetalnom blokadom anestetikom. Primenjivan je uobičajni, standardni protokol anestezije za laparoskopske operacije kod svih ispitanika. Svim bolesnicima plasirana je orogastrična sonda koja se nakon operacije odstranjivala. Kod&nbsp; bolesnika kod kojih je primenjivan lokalni anestetik neposredno pre početka operacije pravio se rastvor lokalnog anestetika (Marcaine&reg; 0,25%). Bolesnici su otpu&scaron;teni sa bolničkog lečenja prvog postoperativnog dana, pod uslovom da nisu imali komplikacija. 5. Postoperativno praćenje i ispunjavanje upitnika. Po dolasku na odeljenje&nbsp; bolesnicima je odmah uključivana ista analgezija. Tokom ispunjavanja informisanog pristanka, bolesnici su dobili upitnik na kojoj će sami procenjivati nivo bola, mučnine i kretanja tokom ležanja u bolnici i vremena praćenja od 7 dana kući. Bolesnici su dolazili na unapred zakazane postoperativne kontrole 7 do 10 dana posle operacije i donosili ispunjene upitnike. Otpu&scaron;teno je i za praćenje ostalo n=302 laparoskopski operisanih bolesnika a isključeno iz studije n=20 bolesnika. 6. Statistička obrada i pisanje rada. Ukupno je analizirano 274 listića operisanih bolesnika: u Grupi P+V =67; u Grupi P =70; u Grupi V =70 i u Grupi O =67. Od osnovnih deskriptivnih statističkih parametara za kvalitativnu i kvantitativnu procenu dobijenih rezultata su kori&scaron;ćeni apsolutni brojevi, relativni brojevi, mediana, mod, aritmetička sredina i standardna devijacija (SD). Obrada podataka se vr&scaron;ila&nbsp; osnovnim i naprednim statističkim metodama i programima. Rezultati su prikazani tabelarno i grafički. REZULTATI. Demografski podaci. Ukupno je bilo 188 žena i 86 mu&scaron;karaca, u odnosu 2,2 : 1. Prosečna starost cele grupe je bila 52,1 &plusmn; 15,72 godine. Ukupno je bilo 179 zaposlenih i 95 nezaposlenih. Ukupno je bilo 45 ispitanika sa osnovnim obrazovanjem, 153 ispitanika sa srednjim obrazovanjem i 76 ispitanika sa visokim obrazovanjem. Ukupno je bilo 186 nepu&scaron;ača i 88 pu&scaron;ača. Prosečna vrednost BMI cele grupe je bila 27,24 &plusmn; 4,21 kg/m2. Prosečna vrednost ASA u celoj grupi je bila 2,03 (mediana=2, mod=2). Ne postoji statistički značajna razlika između posmatranih grupa u odnosu na posmatrane parametre. Laboratorijski podaci. Postoji statistički značajna razlika u vrednosti leukocita između posmatranih grupa (p=0,039), u vrednosti uree između posmatranih grupa (p=0,040). Ne postoji statistički značajna razlika u vrednosti eritrocita, trombocita, hemoglobina, &Scaron;UK-a, kreatinina i bilirubina posmatranih grupa. Operativni i postoperativni podaci. Ne postoji statistički značajna razlika u količini upotrebljenog Fentanila između posmatranih grupa. Postoji statistički značajna razlika u dužini trajanja operacije između posmatranih grupa (p=0,003), u trajanju postavljenog abdominalnog drena između posmatranih grupa (p=0,024), u trajanju hospitalizacije između posmatranih grupa (p=0,027), u broju dana do povratka uobičajenim aktivnostima između posmatranih grupa (p=0,000), u broju uzetih tableta između posmatranih grupa (p=0,000). Prosečna ocena zadovoljstva bolesnika posle operacije u celoj grupi je bila 8,80 (mediana=9; mod=10). Najbolju ocenu zadovoljstva bolesnika posle operacije je imala grupa P+V. Procena bola, mučnine i kretanja. Postoji statistički značajna razlika između posmatranih grupa u proceni jačine bola pre operacije (p=0,003). Postoji statistički značajna razlika između posmatranih grupa u proceni jačine bola 1h posle operacije (najbolju procenu bola je imala grupa P+V); u proceni jačine bola 2h posle operacije (najbolju procenu bola je imala grupa P+V); u proceni jačine bola 4h posle operacije (najbolju procenu bola je imala grupa P); u proceni jačine bola 6h posle operacije (najbolju procenu bola je imala grupa P+V); u proceni jačine bola 12h posle operacije (najbolju procenu bola je imala grupa P+V); u proceni jačine bola 24h posle operacije (najbolju procenu bola je imala grupa P+V); u proceni jačine bola 48h posle operacije (najbolju procenu bola je imala grupa P) i u proceni jačine bola 7 dana posle operacije (najbolju procenu bola je imala grupa P). Procenjena bol se pojačava otprilike 2,5 sata posle operacije sa vrhom 3 sata posle operacije, a smanjuje se na istu vrednost kao 2. sata posle operacije, otprilike 5. sata posle operacije. U vremenskim intervalima 1, 2. i 7. postoperativni dan postoji značajno pobolj&scaron;anje u postoperativnoj mobilnosti bolesnika. U vremenskim intervalima 1, 2, 4, 6 i 12 sati postoji značajno pobolj&scaron;anje u procenjenoj vrednosti mučnine bolesnika. Korelacije. Statistički značajna pozitivna korelacija ocene bola posle 1. sata, posle 2. sata, posle 6. sata, posle 12. sata je utvrđena sa brojem uzetih tableta (p=0,000), kao i procene mučnine (p=0,000). Statistički značajna pozitivna korelacija procene bola posle 4. sata je utvrđena sa brojem uzetih tableta (p=0,006), kao i aktivnosti (p=0,014). Statistički značajna korelacija procene bola posle 24. sata je utvrđena sa brojem uzetih tableta (p=0,000; pozitivna) i trajanjem operacije (p=0,028; negativna). Statistički značajna pozitivna korelacija procene bola posle 48. sata i posle 7 dana je utvrđena sa brojem uzetih tableta (p=0,000). ZAKLJUČCI: Primena lokalnog anestetika datog na bilo koji način značajno smanjuje bol posle laparoskopske holecistektomije. Primena lokalnog anestetika datog i&nbsp; portalno i visceralno (P+V) značajno smanjuje bol u odnosu na samo portalnu (P) ili visceralnu (V) primenu u vremenskim intervalima 2, 6, 12 sat posle laparoskopske holecistektomije. Portalna (P) primena sa ili bez visceralne (V) primene lokalnog anestetika značajno smanjuje bol u vremenskim intervalima 1, 4, 24, 48 sati i 7 dana posle laparoskopske holecistektomije. Najbolje kretanje je bilo u grupi P+V posle laparoskopske holecistektomije. Najbolje smanjenje procenjene mučnine je bilo u grupi P posle laparoskopske holecistektomije. Najraniji povratak uobičajenim aktivnostima zabeležen je u grupi P+V. Najbolja ocena zadovoljstva bolesnika hirur&scaron;kim lečenjem bila je u grupi P+V. Postoperativna bol ima najznačajniju pozitivnu korelaciju sa procenjenom mučninom i brojem tableta uzetih od momenta otpusta do prve kontrole bolesnika.</p> / <p>INTRODUCTION: Biliary calculosis is the most frequent disease of the hepatobiliary system, and cholecystectomy is one of the most frequently performed surgical procedures. Today laparoscopic cholecystectomy represents the golden standard in treating cholelithiasis. Laparoscopic cholecystectomy showed improvement in the clinically significant outcomes, such as: reducing the duration of the surgery, shorter hospital stay, reducing the intensity and duration of postoperative pain and faster return to normal daily and working activities. Postoperative pain and the time of full recovery remain the two major problems after a non-complicated laparoscopic cholecystectomy and they should be improved. The pain related to laparoscopic cholecystectomy is complex and multi-factorial in origin. The pain occurs due to damaged tissues, dissection and removal of gallbladder from its cavity, stimulation of periportal nerves, irritation of the diaphragm, mechanical and chemical interaction of gases and pneumoperitoneum and port incisions. Researches have denoted parietal and visceral pains as two major mechanisms in occurrence of pain in laparoscopic cholecystectomy. Pain cannot be measured, but estimated, as it is a subjective feeling. It was considered necessary to find the answer, based on solid scientific evidence, if it was possible to block parietal and visceral pain after laparoscopic cholecystectomy in its acute phase. OBJECTIVES: The aim of this study is to compare standard, non-opioid, analgesia (group O) with applying parietal blockade (group P), or visceral blockade (group V), or compare with both applied blockades (group P+V). The primary outcomes of the study are the patient&acute;s estimated pain before surgery and 1, 2, 4, 6, 12, 24, 48 hours and 7th day after the surgery. The secondary outcomes of this study are the patient&acute;s estimated nausea level during 1, 2, 4, 6, 12 hours, along with the patient&acute;s estimated mobility 1st, 2nd and 7th day, postoperatively. HYPOTHESIS. Blockade of postoperative visceral pain and blockade of postoperative parietal pain following laparoscopic cholecystectomy, applying intraperitoneal local infiltration with anesthetic and also by local infiltration with anesthetic through accessible laparoscopic ports, can significantly reduce early postoperative pain. MATERIAL AND METHODS: This prospectively randomized single-blinded study started in September 2014 and lasted up to January 2016. The research was carried out at the Clinic for Abdominal, Endocrine and Transplantation Surgery and Emergency Center, Clinical Center of Vojvodina in Novi Sad and it involved patients who underwent laparoscopic cholecystectomy. This study has been divided into several units. 1. Assessment of sample size; 2. Assessment of eligibility for the study; 3. Survey and inclusion in the study; 4. Group formation and operational work; 5. Period of postoperative follow-up; 6. Statistical processing and writing the paper.1. Assessment of sample size. The study was realized by dividing the patients into 4 groups. The number of patients necessary was determined based on the data taken as pilot study from a similar study from 2012. Sample size was calculated for the primary outcome of the study (patient&acute;s estimated pain with NAS) based on the assumption that a pain reduction of 20% should occur during the first postoperative hour, with the probability of Type 1 error &alpha;=0.05 and Type 2 error &beta;=0.10 to reach the adequate statistical power of about 80%, and to reveal 20% difference in the average value of the estimated pain one hour after the laparoscopic cholecystectomy. The assessed number of respondents in groups according to the set criteria was (P+V =65;P =68;V =68; O =65). The study started when the first patient was included and it ended with the complete follow-up period when the last patient handed in the survey about pain, nausea and mobility. 2. Assessment of eligibility for the study. During the study the number of patients undergoing surgery applying the method of cholecystectomy was 1024 (440 classical and 584 laparoscopic). Only the suitable patients were surveyed (584) and given to read the information leaflet about the study. Inclusion and assessment of patients&acute; eligibility was performed on the basis of inclusion and exclusion criteria. A total of 226 patients was not included in the study. Out of that number 82 patients refused to participate in the study and 144 did not fulfill the inclusive criteria set. By signing 358 patients confirmed their participation in the study. 3. Survey and inclusion in the study. After admitting the patients to hospital the surveyors took their anamnesis and the patients were offered an information leaflet and informed consent. Following the reading of the information leaflet, signing the informed consent and satisfying the criteria for inclusion and exclusion, 358 patients were included in the study. Preoperative preparations were performed and the surveyors filled in some of the data on the individual list. 4. Group formation and operational work. Prior to the surgery an independent person not included in the study carried out the randomisation of the patients chosen (n=358) into study groups by random selection tables. The patients did not know which group they belonged to, while it became known to the surgeon and the operation stuff at the beginning of the surgery (singleblinded study). After randomization and surgery the patients belonged to one of the following groups: Control group O=89 of patients with performed laparoscopic cholecystectomy without visceral blockade by anesthetic and without parietal blockade by anesthetic. Experimental group P=88 of patients with performed laparoscopic cholecystectomy without visceral blockade by anesthetic but with parietal blockade by anesthetic. Experimental group V=92 of patients with performed laparoscopic cholecystectomy with visceral blockade by anesthetic but without parietal blockade by anesthetic. Experimental group P+V=89 of patients with performed laparoscopic cholecystectomy with visceral blockade by anesthetic and with parietal blockade by anesthetic. The standard protocol of anesthesia for laparoscopic cholecystectomy was applied to all patients. An orogastric tube used during the surgery, was removed after it. In patients with applied local anesthetic immediately before surgery a solution of local anesthetic was made (Marcaine&reg; 0,25%). The patients were discharged from hospital the first postoperative day, provided that no complications occurred. 5. Postoperative follow-up and completing the questionnaire. When admitted to the ward the patients were given the same kind of analgesia. While completing the informed consent the patients were given a questionnaire for estimating their pain level, nausea and mobility during their stay in hospital and during the 7-day follow-up period at home. The patients were required to come for 7 and 10-day postoperative check-ups by appointment and then they handed in the questionnaires. n=302 patients with performed laparoscopic cholecystectomy were released and designated for follow-up, and n=20 patients were excluded from the study. 6. Statistical processing and writing the paper. In total 274 operated patients&acute; slips were analysed, by groups as follows: in Group P+V =67; in Group P =70; in Group V =70 and in Group O =67. From the basic descriptive statistical parametres for qualitative and quantitative assessment of results obtained, absolute numbers, relative numbers, the median, mode, arithmetic mean and standard deviation (SD) were used. Data processing was carried out using basic and advanced statistical methods and programmes. The results are presented in tabular and graphical manner. RESULTS. Demographic data. In total there were 188 women and 86 men, in proportion 2,2 : 1. The average age of the whole group was 52,1 &plusmn; 15,72 years. In total there were 179 employed and 95 unemployed persons. In total there were 45 surveyed patients with primary education, 153 surveyed patients with secondary education and 76 surveyed patients with higher education. In total there were 186 nonsmokers and 88 smokers. The mean BMI value of the whole group was 27,24 &plusmn; 4,21 kg/m2. The mean value of ASA of the whole group was 2,03 (the median=2, mode=2). There is no significant difference among the groups observed considering the observed parametres. Laboratory data. There is a statistically significant difference in the value of leukocytes among the observed groups (p=0,039), and in the value of urea among the observed groups (p=0,040). There is no statistically significant difference in the value of the erythrocyte, platelets, hemoglobin, blood glucose, creatinine and bilirubin of the&nbsp; observed groups. Operative and postoperative data. There is no statistically significant difference in the amount of Fentanyl&reg; applied among the observed groups. There is statistically significant difference in the length of the surgery among the observed groups (p=0,003), in the duration of the positioning of abdominal drainage among the observed groups (p=0,024), in the duration of hospital stay among the observed groups (p=0,027), in the number of days until getting back to regular activities among the observed groups&nbsp; (p=0,000), in the number of taken pills among the observed groups (p=0,000). The patients&acute; average satisfaction grade after surgery in the whole group was 8,80 (the median=9; mode=10). Group P+V had the best patient&lsquo;s satisfaction grade after the surgery. Assessment of pain, nausea and mobility. There is statistically significant difference in the estimation of pain intensity before surgery among the observed groups (p=0,003). There is statistically significant difference in the estimation of pain intensity 1 hour after surgery among the observed groups (P+V having the best estimated pain); in the estimation of pain intensity 2 hours after&nbsp; surgery (P+V having the best estimated pain); in the estimation of pain intensity 4 hours after surgery (P having the best estimated pain); in the estimation of pain intensity 6 hours after surgery (P+V having the best estimated pain); in the estimation of pain intensity 12 hours after surgery (P+V having the best estimated pain); in the estimation of pain intensity 24 hours after surgery (P+V having the best estimated pain); in the estimation of pain intensity 48 hours after surgery (P having the best estimated pain) also in the estimation of pain intensity 7 days after surgery (P having the best estimated pain). The estimated pain intensifies at about 2,5 hours after surgery and peaks 3 hours after surgery, and decreases to the same level as it was during 2nd hour after surgery approximately during 5th hour after surgery. There is considerable improvement in mobility of patients in the time interval 1st, 2nd and 7th postoperative days. There is considerable improvement in estimated nausea level of patients in the time interval 1, 2, 4, 6 and 12 hours. Correlations. Statistically significant positive correlation in estimated pain after 1st hour, after 2nd hour, after 6th hour and after 12th hour was determined by the number of tablets taken (p=0,000), just like the estimated nausea level (p=0,000). Statistically significant positive correlation in estimated pain after 4th hour was determined by the number of tablets taken (p=0,006), just like the activities (p=0,014). Statistically significant positive correlation in estimated pain after 24th hour was determined by the number of tablets taken (p=0,000; positive), and by the duration of the surgery (p=0,028; negative). Statistically significant positive correlation in estimated pain after 48th hour and after 7 days was determined by the number of tablets taken (p=0,000). CONCLUSIONS: The application of local anesthetic, regardless of how it was applied, considerably reduces pain after laparoscopic cholecystectomy. The application of local anesthetic by port or viscerally (P+V) considerably reduces pain compared to only by port (P) or only visceral (V) application in the time intervals of 2, 6, and 12 hours after laparoscopic cholecystectomy. The application of local anesthetic by port (P), with or without visceral (V), considerably reduces pain in the time intervals of 1, 4, 24, and 48 hours and 7 days after laparoscopic cholecystectomy. The best mobility was shown by group P+V after laparoscopic cholecystectomy. Estimated nausea was most reduced in group P after laparoscopic cholecystectomy. Group P+V presented the earliest return to regular activities. The best patients&acute; satisfaction grade with surgical treatment was shown by group P+V. Postoperative pain is most considerably positively correlated with the estimated nausea and pills taken, from the moment of patient&acute;s release from hospital to the first check-up.<br />&nbsp;</p>

Page generated in 0.0938 seconds